glucagon receptor antagonists (Mitsubishi Tanabe Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameglucagon receptor antagonists (Mitsubishi Tanabe Pharma)
Drug Alias Nameglucagon receptor antagonists (Mitsubishi Tanabe Pharma)GCGR-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon receptor antagonists
TargetsGlucagon receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A